{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:14:01Z","timestamp":1787944441665,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ymgme.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:51:28Z","timestamp":1629208288000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model"],"prefix":"10.1016","volume":"134","author":[{"given":"Jenny A.","family":"Greig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Jennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Chorazeczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.08.003_bb0005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gim.2013.177","article-title":"Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings","volume":"16","author":"Hinton","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2014.07.009","article-title":"Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning","volume":"113","author":"Therrell","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1096-7192(03)00144-6","article-title":"Relationship of causative genetic mutations in maple syrup urine disease with their clinical expression","volume":"80","author":"Nellis","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0020","first-page":"22","article-title":"Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population","volume":"17","author":"Ali","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/humu.9187","article-title":"Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease","volume":"22","author":"Henneke","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/humu.9428","article-title":"Mutational spectrum of maple syrup urine disease in Spain","volume":"27","author":"Rodriguez-Pombo","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1086\/323677","article-title":"Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population","volume":"69","author":"Edelmann","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0040","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1007\/s10545-010-9129-z","article-title":"Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan","volume":"33","author":"Niu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain alpha-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1542\/peds.109.6.999","article-title":"Diagnosis and treatment of maple syrup disease: a study of 36 patients","volume":"109","author":"Morton","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2021.08.003_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1005433516026","article-title":"4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)\u2013the odour of maple syrup urine disease","volume":"22","author":"Podebrad","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0065","article-title":"yperleucinosis during infections in maple syrup urine disease post liver transplantation","volume":"27","author":"Guilder","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ajcn\/68.1.72","article-title":"A molecular model of human branched-chain amino acid metabolism","volume":"68","author":"Suryawan","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/TP.0000000000002300","article-title":"Domino liver transplant in maple syrup urine disease: technical details of cases in which the first surgery involved a living donor","volume":"103","author":"Roda","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ymgme.2021.08.003_bb0080","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.transproceed.2012.04.031","article-title":"Domino liver transplantation in maple syrup urine disease: a case report and review of the literature","volume":"45","author":"Badell","year":"2013","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2350-7-33","article-title":"Production and characterization of murine models of classic and intermediate maple syrup urine disease","volume":"7","author":"Homanics","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10545-009-1086-z","article-title":"Animal models of maple syrup urine disease","volume":"32","author":"Skvorak","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.08.017","article-title":"Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates","volume":"13","author":"Gao","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112268","article-title":"Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression","volume":"9","author":"Greig","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2021.08.003_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymthe.2006.03.008","article-title":"Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver","volume":"14","author":"Bell","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/hum.2011.183","article-title":"Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector","volume":"23","author":"Wang","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0115","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ymthe.2019.10.005","article-title":"Liver gene therapy: reliable and durable?","volume":"27","author":"Herzog","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0120","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1016\/j.vaccine.2016.10.053","article-title":"Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques","volume":"34","author":"Greig","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ymgme.2021.08.003_bb0125","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0130","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2021.08.003_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221007678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:50:23Z","timestamp":1761090623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221007678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1096719221007678"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle-directed AAV gene therapy rescues the maple syrup urine disease phenotype in a mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}